Relx (RELX) – Analysts’ Weekly Ratings Updates
by Teresa Graham · The Cerbat GemA number of research firms have changed their ratings and price targets for Relx (NYSE: RELX):
- 5/17/2026 – Relx was downgraded by Wall Street Zen from “buy” to “hold”.
- 5/9/2026 – Relx was upgraded by Wall Street Zen from “hold” to “buy”.
- 5/8/2026 – Relx had its “hold (c)” rating reaffirmed by Weiss Ratings.
- 5/7/2026 – Relx was downgraded by Morgan Stanley from “overweight” to “equal weight”.
- 4/8/2026 – Relx was upgraded by Citigroup Inc. from “neutral” to “buy”.
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.